Duloxetine 30mg Capsules Recalled Due to Nitrosamine Impurity
Breckenridge Pharmaceutical is recalling 163,883 bottles of Duloxetine 30mg capsules nationwide due to N-nitroso-duloxetine impurity above FDA-recommended limits.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II recall of a prescription drug containing N-nitroso-duloxetine impurity above FDA-recommended limits. N-nitroso compounds are potentially genotoxic, constituting a risk-of-harm situation where injury has not yet been reported, meeting the rubric criterion for High severity.
Plain-English summary
Breckenridge Pharmaceutical, Inc. is recalling Duloxetine Hydrochloride 30mg delayed-release capsules distributed nationwide in the United States. The recall affects 163,883 bottles (NDC 51991-747-90, 90-count bottles) manufactured by Towa Pharmaceutical Europe in Spain. The affected lot number is 222205C with an expiration date of November 2025.
The recall was initiated due to Current Good Manufacturing Practice (CGMP) deviations identified during manufacturing. Specifically, N-nitroso-duloxetine impurity was detected above the FDA-recommended interim limit. N-nitroso compounds are known to be potentially genotoxic.
The recalled product
- Product
- DULOXETINE (DULOXETINE HYDROCHLORIDE)
- Brand
- DULOXETINE
- Manufacturer
- Breckenridge Pharmaceutical, Inc
- Category
- Drug
- Hazard
- nitrosamine
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot # 222205C
- exp. date 11/2025
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · DULOXETINE
- ModerateDuloxetine delayed-release capsules recalled for N-nitroso impurity contamination
FDA (Drugs) · 2026-05-13
- ModerateDuloxetine Delayed-Release Capsules 20 mg Recalled for Impurity
FDA (Drugs) · 2026-05-13
- ModerateDuloxetine Delayed-Release Capsules Recalled for Impurity Above FDA Limit
FDA (Drugs) · 2026-05-13
- ModerateDuloxetine Delayed-Release Capsules Recalled for Impurity Above Limit
FDA (Drugs) · 2026-05-13
- HighPrescription Duloxetine Capsules Recalled for Nitrosamine Impurity
FDA (Drugs) · 2025-04-09
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- HighBeak & Skiff Alcohol Antiseptic Sanitizer recalled for acetaldehyde contamination
FDA (Drugs) · 2026-06-17
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- SevereCIMZIA injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-05-27